Chimeric antigen receptor-engineered natural killer cells: a promising cancer immunotherapy
Year: 2021
Type: review
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W3152461224
